Ningbo Tianyi Medical Appliance Co., Ltd. (SHE:301097)
China · Delayed Price · Currency is CNY 56.52
+0.36 (0.64%)
Feb 11, 2026, 4:00 PM EST
SHE:301097 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 489.2 | 413.93 | 375.71 | 392.02 | 405.26 | 364.92 |
Other Revenue | 5.03 | 5.03 | 5.21 | 7.31 | 9.47 | 13.96 |
| 494.23 | 418.96 | 380.92 | 399.33 | 414.73 | 378.87 | |
Revenue Growth (YoY) | 18.40% | 9.98% | -4.61% | -3.72% | 9.46% | 19.78% |
Cost of Revenue | 306.3 | 270.81 | 238.63 | 260.4 | 257.24 | 216.15 |
Gross Profit | 187.93 | 148.14 | 142.3 | 138.92 | 157.5 | 162.72 |
Selling, General & Admin | 115.99 | 107.39 | 75.37 | 46.23 | 33.18 | 31.96 |
Research & Development | 57.29 | 60.47 | 31.1 | 28.06 | 20.26 | 15.97 |
Other Operating Expenses | 3.17 | 2.84 | 4.69 | 4.5 | 5.37 | 4.69 |
Operating Expenses | 184.01 | 173.85 | 110.72 | 81.27 | 59.15 | 53.03 |
Operating Income | 3.93 | -25.71 | 31.57 | 57.66 | 98.35 | 109.69 |
Interest Expense | -11.59 | -9.78 | -9.9 | -6.79 | -7.08 | -3.43 |
Interest & Investment Income | 18.35 | 21.43 | 37.18 | 6.55 | 2.49 | 2.4 |
Currency Exchange Gain (Loss) | 6.97 | 6.97 | 4.05 | 26.25 | -7.01 | -11.45 |
Other Non Operating Income (Expenses) | -2.17 | -0.94 | 0.01 | -0.87 | -0.68 | -1.09 |
EBT Excluding Unusual Items | 15.48 | -8.02 | 62.91 | 82.8 | 86.06 | 96.12 |
Gain (Loss) on Sale of Investments | -1.74 | 4.22 | 5.01 | 9.62 | -0.11 | 0.13 |
Gain (Loss) on Sale of Assets | 0.27 | -0.22 | -0.05 | -0.22 | 0.81 | -0.03 |
Asset Writedown | -0.55 | -0.08 | -0.06 | -4.79 | -0.82 | -1.13 |
Other Unusual Items | 0.97 | 0.97 | 4.3 | 11.53 | 3.65 | 5.68 |
Pretax Income | 14.43 | -3.14 | 72.1 | 98.94 | 89.6 | 100.77 |
Income Tax Expense | 2.25 | 3.09 | 11.95 | 13.72 | 11.3 | 13.62 |
Earnings From Continuing Operations | 12.18 | -6.22 | 60.15 | 85.22 | 78.29 | 87.15 |
Minority Interest in Earnings | 0.82 | 5.48 | 3.42 | 0.38 | - | - |
Net Income | 13.01 | -0.74 | 63.57 | 85.6 | 78.29 | 87.15 |
Net Income to Common | 13.01 | -0.74 | 63.57 | 85.6 | 78.29 | 87.15 |
Net Income Growth | 46.41% | - | -25.74% | 9.34% | -10.16% | 37.89% |
Shares Outstanding (Basic) | 75 | 74 | 59 | 55 | 44 | 44 |
Shares Outstanding (Diluted) | 75 | 74 | 59 | 55 | 44 | 44 |
Shares Change (YoY) | 29.92% | 26.39% | 6.58% | 24.92% | -0.06% | 4.99% |
EPS (Basic) | 0.17 | -0.01 | 1.08 | 1.55 | 1.77 | 1.97 |
EPS (Diluted) | 0.17 | -0.01 | 1.08 | 1.55 | 1.77 | 1.97 |
EPS Growth | 12.69% | - | -30.32% | -12.43% | -10.15% | 31.33% |
Free Cash Flow | -173.5 | -48.14 | -148.52 | -98.91 | 66.75 | 53.3 |
Free Cash Flow Per Share | -2.30 | -0.65 | -2.52 | -1.79 | 1.51 | 1.21 |
Dividend Per Share | 0.500 | 0.500 | 0.502 | 0.500 | 0.250 | - |
Dividend Growth | -0.32% | -0.32% | 0.32% | 100.00% | - | - |
Gross Margin | 38.02% | 35.36% | 37.36% | 34.79% | 37.97% | 42.95% |
Operating Margin | 0.80% | -6.14% | 8.29% | 14.44% | 23.71% | 28.95% |
Profit Margin | 2.63% | -0.18% | 16.69% | 21.44% | 18.88% | 23.00% |
Free Cash Flow Margin | -35.10% | -11.49% | -38.99% | -24.77% | 16.09% | 14.07% |
EBITDA | 51.4 | 16.21 | 66.08 | 86.4 | 121.35 | 131.52 |
EBITDA Margin | 10.40% | 3.87% | 17.35% | 21.64% | 29.26% | 34.71% |
D&A For EBITDA | 47.47 | 41.92 | 34.5 | 28.75 | 23 | 21.83 |
EBIT | 3.93 | -25.71 | 31.57 | 57.66 | 98.35 | 109.69 |
EBIT Margin | 0.80% | -6.14% | 8.29% | 14.44% | 23.71% | 28.95% |
Effective Tax Rate | 15.59% | - | 16.57% | 13.87% | 12.62% | 13.52% |
Revenue as Reported | 494.23 | 418.96 | 380.92 | 399.33 | 414.73 | 378.87 |
Advertising Expenses | - | 2.95 | 4.5 | 1.2 | 1.04 | 1.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.